Wuhan Union Hospital, China: Lung Neoplasms trials

The registry lists 10 Lung Neoplasms studies with Wuhan Union Hospital, China as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）RecruitingNCT06500312
• Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant ImmunochemotherapyNot yet recruitingNCT06285058
• Multi-dimensional Signatures for Precisely Predicting the Response and Prognosis of Lung Cancer PatientsStatus unknownNCT04980352
• Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLCStatus unknownNCT04943029Phase 2
• A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung CancerStatus unknownNCT04647357Phase 2
• Anlotinib In Combination With Durvalumab As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm StudyStatus unknownNCT04314297Phase 2
• Imaging-based Deep Learning for Lung Cancer Diagnosis and StagingStatus unknownNCT04000620
• Clinical Significance of Computer Aided Image Analysis in Treatment Response Evaluation of Lung CancerStatus unknownNCT03954847
• Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer DiagnosisCompletedNCT03830619
• Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLCStatus unknownNCT02250846Phase 2